ARS Pharmaceuticals, Inc. (SPRY) Stock Ticker
SPRY right now
Market factors today
Unlock the full SPRY picture
About ARS Pharmaceuticals, Inc.
ARS Pharmaceuticals, Inc. specializes in creating ARS-1, an innovative intranasal epinephrine spray utilizing advanced absorption technology. This product serves as a crucial intervention for individuals and their households who are susceptible to life-threatening allergic reactions caused by food, pharmaceuticals, or insect stings. Among its offerings is Neffy, a low-dose version of its intranasal epinephrine nasal spray. Established in 2015, the firm operates out of San Diego, California.
SPRY stock facts
| Ticker symbol | SPRY |
| Exchange | NASDAQ Global Market |
| Sector | Healthcare |
| Industry | Biotechnology |
| Market cap | $405.2M |
| CEO | Donn Casale |
| Employees | 195 |
| Headquarters | San Diego, CA, US |
| IPO date | 2020-12-04 |
| Website | ars-pharma.com |
What you can see for SPRY on Tickr
Live SPRY price chart with overlays, the options chain, implied move, IV rank, options flow and Strategy Lab, financial statements and consensus estimates, analyst ratings, catalysts, news with AI scoring, and an AI chat that has read the SPRY report.
Rankings
SPRY peers
FAQ
What is the ticker symbol for ARS Pharmaceuticals, Inc.?
The ticker symbol for ARS Pharmaceuticals, Inc. is SPRY, listed on the NASDAQ Global Market.
What is SPRY?
ARS Pharmaceuticals, Inc. specializes in creating ARS-1, an innovative intranasal epinephrine spray utilizing advanced absorption technology. This product serves as a crucial intervention for individuals and their households who are susceptible to life-threatening allergic reactions caused by food, pharmaceuticals, or insect stings. Among its offerings is Neffy, a low-dose version of its…